|
|
|
|
Patients �80 years of age appear to have a lower probability of gaining favourable outcome and a higher mortality rate compared with patients <80 years old; however, the rate of SICH was not significantly increased. This supports recruitment of patients aged �80 years into ongoing trials comparing thrombolysis with controls. For patients who refuse or cannot be randomized, it provides information on risks and benefits of using alteplase off-licence. |
|